Be-Sheng Kuo
Corporate Officer/Principal bei AbGenomics International, Inc.
Profil
Be-Sheng Kuo is Senior Director of Preclinical Development for AbGenomics International, Inc. He was a Senior Scientist II at IDEC Pharmaceuticals Corp.
(now known as Biogen IDEC, Inc.) from 1999 to 2003, Parke-Davis Pharmaceutical Research, Inc. (now known as Pfizer, Inc.) from 1993 to 1999, and Marion Merrell Dow, Inc. from 1988 to 1993.
Dr. Kuo received a PhD in Biopharmaceutics from University of Cincinnati.
Aktive Positionen von Be-Sheng Kuo
| Unternehmen | Position | Beginn |
|---|---|---|
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Be-Sheng Kuo
| Unternehmen | Position | Ende |
|---|---|---|
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
| Parke-Davis Pharmaceutical Research, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 |
| Marion Merrell Dow, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 |
Ausbildung von Be-Sheng Kuo
| University of Cincinnati (Ohio) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
| Marion Merrell Dow, Inc. | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
| Parke-Davis Pharmaceutical Research, Inc. |
